Influence of therapy chronic heart failure of functional class III on regulatory adaptive status
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD). All them administered of complex therapy (Quinapril, Torasemide, Spironolactone).
E. S. Rokotyanskaya
doaj
OBJECTIVES: To compare the hemodynamic effects of twice daily metoprolol tartrate (MT) and once daily metoprolol succinate (MS) in congestive heart failure patients.
Kalman, Jill, MD +5 more
core +1 more source
Aim. To identify the optimal therapeutic strategy in Functional Class (FC) I–II chronic heart failure (CHF), in accordance with the effects of different drug classes on the regulatory and adaptive status (RAS). Material and methods.
S. G. Kanorskyi +2 more
doaj
Drug-induced Raynaud phenomenon following initiation of metoprolol succinate. [PDF]
Sahoo S, Gavin MC, Cluett JL.
europepmc +1 more source
A stability-indicating potentiometric platform for assaying Metoprolol succinate and felodipine in their tablets and human plasma. [PDF]
El Fiky HA +5 more
europepmc +1 more source
A comparison of anti-arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter-defibrillators. [PDF]
Ayan M +6 more
europepmc +1 more source
Comparative Effectiveness of Bisoprolol, Carvedilol, and Metoprolol Succinate in Patients with Heart Failure and CKD. [PDF]
Huang CW +7 more
europepmc +1 more source
Development of a sustained-release microcapsule for delivery of metoprolol succinate. [PDF]
Song L, He S, Ping Q.
europepmc +1 more source
Comparison of the efficacy, safety, and tolerability of the FDC of telmisartan + bisoprolol with telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: A double-blind, multicentric, phase-III clinical study. [PDF]
Wander GS +11 more
europepmc +1 more source

